Azenta has selected the greater Boston area, a key pharma and biotech hub, as
the next location to expand its global biorepository
footprint.
BURLINGTON, Mass., June 29,
2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA)
today announced it is opening a new location in the greater
Boston area to expand its global
sample storage business into the Boston market. The 40,000 square foot
facility, located in Billerica,
MA, will be Azenta's second largest biorepository in terms
of sample capacity after its flagship Indianapolis location.
The project is leveraging a new, highly efficient building
footprint providing capacity for the latest ultra-cold storage and
automation capabilities. The biorepository will provide
storage across a range of temperatures down to -190℃ for biological
samples and products regulated under GMP and GTP, including
cellular therapies. The site will feature state-of-the-art
automation, including Azenta's automated cryogenic freezers and the
Azenta BioStore™ automated sample store. Azenta's unique sample
management capabilities also include 24/7 visibility of collections
at the individual sample level using 21 CFR, Part 11 compliant
software. Similar to the Indianapolis location, all of the site's
electricity will come from renewable sources via annual purchases
of renewable energy credits, in support of Azenta's commitment to
sustainability and the environment.
"We are excited to announce our new biorepository in the greater
Boston area," stated Kathi Shea, Vice President, Repository and
Innovation. "After significant interest from our customers, we have
decided to make a meaningful investment in our sample storage
capabilities serving this innovative and growing life sciences
market. The new facility will provide Boston area customers our well-established
biorepository expertise with same-day access to samples. In
addition, we believe this will bring true cost optimization to the
Boston market, easing the
high-cost real estate burden for local management of highly
sensitive assets and enabling seamless archival to Indianapolis as needed."
The site is expected to begin operations towards the end of
calendar year 2023. The Boston
biorepository represents the ninth biorepository in the Company's
global repository network, which spans North America, Europe, and Asia.
About Azenta Life Sciences
Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life
sciences solutions worldwide, enabling impactful breakthroughs and
therapies to market faster. Azenta provides a full suite of
reliable cold-chain sample management solutions and multiomic
services across areas such as drug development, clinical research
and advanced cell therapies for the industry's top pharmaceutical,
biotech, academic and healthcare institutions globally.
Azenta is headquartered in Burlington, Massachusetts, with operations in North
America, Europe and Asia. For more information,
please visit www.azenta.com.
CONTACTS:
Sara Silverman
Head of Investor Relations & Corporate Communications
ir@azenta.com
Sherry Dinsmore
sherry.dinsmore@azenta.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/azenta-announces-new-biorepository-in-the-greater-boston-area-301867473.html
SOURCE Azenta